Bhatia Sangeeta R, Miedel Mark T, Chotoo Cavita K, Graf Nathan J, Hood Brian L, Conrads Thomas P, Silverman Gary A, Luke Cliff J
Department of Pediatrics, Children's Hospital of Pittsburgh, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
Methods Enzymol. 2011;499:283-99. doi: 10.1016/B978-0-12-386471-0.00014-6.
Most serpins inhibit serine and/or cysteine proteases, and their inhibitory activities are usually defined in vitro. However, the physiological protease targets of most serpins are unknown despite many years of research. This may be due to the rapid degradation of the inactive serpin:protease complexes and/or the conditions under which the serpin inhibits the protease. The model organism Caenorhabditis elegans is an ideal system for identifying protease targets due to powerful forward and reverse genetics, as well as the ease of creating transgenic animals. Using combinatorial approaches of genetics and biochemistry in C. elegans, the true in vivo protease targets of the endogenous serpins can be elucidated.
大多数丝氨酸蛋白酶抑制剂(serpins)抑制丝氨酸和/或半胱氨酸蛋白酶,其抑制活性通常在体外进行定义。然而,尽管经过多年研究,大多数丝氨酸蛋白酶抑制剂的生理蛋白酶靶点仍不明确。这可能是由于无活性的丝氨酸蛋白酶抑制剂:蛋白酶复合物快速降解和/或丝氨酸蛋白酶抑制剂抑制蛋白酶的条件所致。模式生物秀丽隐杆线虫由于具有强大的正向和反向遗传学以及易于创建转基因动物,是鉴定蛋白酶靶点的理想系统。利用秀丽隐杆线虫中遗传学和生物化学的组合方法,可以阐明内源性丝氨酸蛋白酶抑制剂的真正体内蛋白酶靶点。